Early research (Phase 1)UnknownNCT05302843What this trial is testingBPI-28592 in Subjects With Advanced Solid TumorsWho this might be right forMetastasis, Neoplasm Betta Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Early research (Phase 1)Ended earlyNCT04835714What this trial is testingFind a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])Who this might be right forSolid Tumors, KRAS Mutation Boehringer Ingelheim 8
Early research (Phase 1)Study completedNCT04330664What this trial is testingAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 86
Early research (Phase 1)Looking for participantsNCT05857332What this trial is testingSG1906 for CLDN18.2-Positive Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Hangzhou Sumgen Biotech Co., Ltd. 60
Early research (Phase 1)Study completedNCT01919398What this trial is testingLY2940680 in Japanese Participants With Advanced CancersWho this might be right forNeoplasm Metastasis Eli Lilly and Company 19
Testing effectiveness (Phase 2)Study completedNCT00526045What this trial is testingPhase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsWho this might be right forBreast CancerHematologic Neoplasms Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872What this trial is testingStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsWho this might be right forSolid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT01554371What this trial is testingEribulin in Combination With Cyclophosphamide in Patients With Solid Tumor MalignanciesWho this might be right forMalignant Solid TumourBreast Cancer Nos Metastatic RecurrentNeuropathy University of California, San Francisco 44
Testing effectiveness (Phase 2)Ended earlyNCT00814463What this trial is testingStereotactic Radiosurgery After Surgery in Treating Patients With Brain MetastasesWho this might be right forMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific Duke University 1
Early research (Phase 1)Study completedNCT04094506What this trial is testingStudy of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid TumorsWho this might be right forLocally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Astellas Pharma Inc 9
Early research (Phase 1)Study completedNCT02004106What this trial is testingEvaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid TumorsWho this might be right forNeoplasms Hoffmann-La Roche 110
Early research (Phase 1)UnknownNCT03415100What this trial is testingPilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid TumoursWho this might be right forSolid Tumours The Third Affiliated Hospital of Guangzhou Medical University 30
Not applicableEnded earlyNCT02269111What this trial is testingQuantitative MRI in Assessing Disease in Patients With Brain TumorsWho this might be right forTumors Metastatic to BrainUnspecified Adult Solid Tumor, Protocol Specific Vanderbilt-Ingram Cancer Center 10
Early research (Phase 1)Looking for participantsNCT06349408What this trial is testingIBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Solid Tumor Innovent Biologics (Suzhou) Co. Ltd. 250
Early research (Phase 1)Looking for participantsNCT05791448What this trial is testingAU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic DiseaseWho this might be right forAdvanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more University of Southern California 36
Testing effectiveness (Phase 2)UnknownNCT03961698What this trial is testingEvaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaWho this might be right forBreast CancerRenal Cell Carcinoma Infinity Pharmaceuticals, Inc. 91
Early research (Phase 1)Study completedNCT03009214What this trial is testingA Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid TumoursWho this might be right forMalignant Solid Tumor amcure GmbH 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176What this trial is testingIntratumoral N17350 in Advanced Solid TumorsWho this might be right forNeoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more Onchilles Pharma Inc 275
Not applicableStudy completedNCT02385604What this trial is testingThe Predictive Value of CT-PET in Esophageal CancerWho this might be right forEsophageal Neoplasms St. James's Hospital, Ireland 250